Journals / Veterinary Sciences and Practices / 2018 / Cilt: 13 Sayı: 2

Protective Effects of Naringin on Liver Enzymes (AST, ALT, ALP) and Histopathology in Cyclophosphamide-Induced Rats

Cyclophosphamide İle İndüklenmiş Ratlarda Karaciğer Enzimleri (AST, ALT, ALP) ve Histopatolojisi Üzerine Naringin’in Protektif Etkileri

Pages
182–190
Publication Date
2018-10-25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, different doses of Naringin were determined to be protective effective for CYP-induced hepatotoxicity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, it is aimed to investigate the protective effects of Naringin on liver enzymes (Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Alkaline Phosphatase (ALP) and histopathology in CYP-induced rats.
📊
Key Findings & Data:In our study, forty male adult Sprague Dawley rat weighing approximately 200-250 g were used and 5 gropus formed.
💡
Conclusion & Impact:In conclusion, different doses of Naringin were determined to be protective effective for CYP-induced hepatotoxicity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Cyclophosphamide · Histopatoloji · Karaciğer Enzimleri

Abstract

In this study, it is aimed to investigate the protective effects of Naringin on liver enzymes (Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Alkaline Phosphatase (ALP) and histopathology in CYP-induced rats. In our study, forty male adult Sprague Dawley rat weighing approximately 200-250 g were used and 5 gropus formed. Analyzes of liver enzymes were done in auto analyzer and spectrophotometer. The liver tissue samples stained with hematoxylin eosin were examined by light microscopy. CYP was found to cause hapatotoxicity and showed increased liver enzymes in rats. AST, ALT and ALP values were 58±11, 32±8, 38±6 in the control group; 237±42, 168±44, 74±11 in the CYP group; 223±33, 158±42, 62±9 in the Naringin 50+CYP group; 117±25, 107±24, 48±8 in Naringin 100+CYP group; 54±9, 31±7, 36±6 in the group of Naringin 100 were found respectively. According to the values obtained from the control group, there is an increase of P<0.001 in all of the AST, ALT and ALP values in CYP-treated groups. Degenerative and necrotic tissue damage caused by CYP in the liver tissue was found to be reduced as dose-dependent with effect of Naringin. In conclusion, different doses of Naringin were determined to be protective effective for CYP-induced hepatotoxicity.

Özet

Bu çalışmada Cyclophosphamide (CYP) uygulaması yapılan ratlarda karaciğer enzimleri (Aspartat aminotransferaz (AST), Alanin aminotransferaz (ALT), Alkalen fosfataz (ALP) ve histopatolojisi üzerine Naringin’in protektif etkilerinin araştırılması amaçlanmaktadır. Araştırmamızda yaklaşık 200-250 g ağırlığında, 40 adet erkek erişkin Sprague Dawley ırkı rat kullanıldı ve 5 grup oluşturuldu. Karaciğer enzimlerinin analizleri otoanalizörde ve spektrofotometrede yapıldı. Hematoksilen eosin ile boyanan karaciğer doku örnekleri ışık mikroskobunda incelendi. CYP’nin ratlarda hepatotoksiteye yol açtığı ve karaciğer enzimlerini artırdığı görüldü. AST, ALT ve ALP değerleri Kontrol grubunda 58±11, 32±8, 38±6; CYP grubunda 237±42, 168±44, 74±11; Naringin 50+CYP grubunda 223±33, 158±42, 62±9; Naringin 100+CYP grubunda 117±25, 107±24, 48±8; Naringin 100 grubunda ise 54±9, 31±7, 36±6 sırasıyla olarak bulundu. Kontrol grubundan elde edilen değerlere göre CYP verilen gruplarda ki AST, ALT ve ALP değerlerinin tamamında P<0.001 düzeyinde artış söz konusudur. CYP’nin karaciğer dokusunda oluşturduğu dejeneratif ve nekrotik doku hasarının Naringin’in etkisiyle dozlara bağlı olarak azaldığı saptandı. Sonuç olarak, Naringin’in farklı dozlarının, CYP ile indüklenen hepatotoksisitede protektif etkili olduğu belirlendi.

🔖

Cite This Article

BÜLBÜL, G. Y., MİS, L., ŞENGÜL, E., YILDIRIM, S., ÇELEBİ, F., ÇINAR, A. (2018). Protective Effects of Naringin on Liver Enzymes (AST, ALT, ALP) and Histopathology in Cyclophosphamide-Induced Rats. Veterinary Sciences and Practices, Cilt: 13 Sayı: 2, 182–190. https://ajindex.com/articles/917294

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ernest E., Cassiletth B., 1998. The prevealence of complementary. Alternative medicine in cancer. Cancer, 83, 777-782
  2. Akay H., Akay T., Seçilmiş S., Koçak Z., Donderici O., 2006. Hepatotoxcity after low-dose cyclophosphamide. South Med J, 99, 1399-1400
  3. DeSouza L., Shen Y., Bognar AL., 2000. Disruption of cytoplasmic and mitochondrial folylpolyglutamate synthetase activity in Saccharomyces cerevisiae. Arch Biochem Biophys, 376, 299-312
  4. Meirow D., Assad G., Dor J., Rabinovici J., 2004. The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice. Hum Reprod, 19, 1294-1299
  5. Thatcher RW., Walker RA., Gerson I., Geisler FH., 1989, EEG discriminant analyses of mild head trauma. EEG Clin Neurophysiol, 73, 94-106
  6. Muratori L., Ferrari R., Muratori P., Granito A., Bianchi FB., 2005. Acute icteric hepatitis induced by a short course of low-dose cyclophosphamide in a patient with lupus nephritis. Dig Dis Sci, 50, 2364-2365
  7. Webb H., Jaureguiberry G., Dufek S., Tullus K., Bockenhauer D., 2016. Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome. Pediatr Nephrol, 31, 589-594
  8. Doğan Z., Kocahan S., Erdemli E., Köse E., Yılmaz I., Ekincioğlu Z., Ekinci N., Turkoz Y., 2015. Effect of chemotherapy exposure prior to pregnancy on fetal brain tissue and the potential protective role of quercetin. Cytotechnology, 67, 1031-1038
  9. Nafees S., Rashid S., Ali N., Hasan SK., Sultana S., 2015. Rutin ameliorates cyclophosphamide induced oxidative stress and inflammation in Wistar rats: role of NFκB/MAPK pathway. Chem Biol Interact, 231, 98-107
  10. Bacanlı M., Başaran AA., Başaran N., 2015. The antioxidant and antigenotoxic properties of citrus phenolics limonene and naringin. Food Chem Toxicol, 81, 160-170
  11. Galati EM., Monforte MT., d’Aquino A., Miceli N., Di Mauro D., Sanogo R., 1998. Effects of naringin on experimental ulcer in rats. Phytomedicine, 5, 361-366
  12. Xie Y., Yang W., Tang F., Chen X., Ren L., 2015. Antibacterial activities of flavonoids: structure-activity relationship and mechanism. Curr Med Chem, 22, 132-149
  13. Liu, L., Zuo, Z., Lu, S., Liu, A., & Liu, X. (2017). Naringin attenuates diabetic retinopathy by inhibiting inflammation, oxidative stress and NF-κB activation in vivo and in vitro. IJBMS, 20(7), 813
  14. Ueng YF., Chang YL., Oda Y., Park SS., Liao JF., Lin MF., Chen CF., 1999. In vitro and in vivo effects of naringin on cytochrome P450-depend